tetano
Editor, Senior Moderator
Eur J Med Res
. 2021 May 14;26(1):45.
doi: 10.1186/s40001-021-00515-9.
Patient hematology during hospitalization for viral pneumonia caused by SARS-CoV-2 and non-SARS-CoV-2 agents: a retrospective study
Bingke Bai[SUP] 1 [/SUP], Zhe Xu[SUP] #[/SUP][SUP] 2 [/SUP], Yan Hu[SUP] #[/SUP][SUP] 1 [/SUP], Mengmeng Qu[SUP] 1 [/SUP], Juan Cheng[SUP] 2 [/SUP], Shengdong Luo[SUP] 1 [/SUP], Zengtao Yao[SUP] 1 [/SUP], Hongyan Gao[SUP] 1 [/SUP], Yenv Ma[SUP] 1 [/SUP], Rong Gao[SUP] 1 [/SUP], Jun Hou[SUP] 1 [/SUP], Shaojie Xin[SUP] 3 [/SUP], Panyong Mao[SUP] 4 [/SUP]
Affiliations
Abstract
Background: Hematological comparison of coronavirus disease (COVID-19) and other viral pneumonias can provide insights into COVID-19 treatment.
Methods: In this retrospective case-control single-center study, we compared the data of 126 patients with viral pneumonia during different outbreaks [severe acute respiratory syndrome (SARS) in 2003, influenza A (H1N1) in 2009, human adenovirus type 7 in 2018, and COVID-19 in 2020].
Results: One of the COVID-19 characteristics was a continuous decline in the hemoglobin level. The neutrophil count was related to the aggravation of COVID-19 and SARS. Thrombocytopenia occurred in patients with SARS and severe COVID-19 even at the recovery stage. Lymphocytes were related to the entire course of adenovirus infection, recovery of COVID-19, and disease development of SARS.
Conclusions: Dynamic changes in hematological counts could provide a reference for the pathogenesis and prognosis of pneumonia caused by respiratory viruses in clinics.
Keywords: Adenovirus; COVID-19; H1N1; Hematology; SARS-CoV-2.
. 2021 May 14;26(1):45.
doi: 10.1186/s40001-021-00515-9.
Patient hematology during hospitalization for viral pneumonia caused by SARS-CoV-2 and non-SARS-CoV-2 agents: a retrospective study
Bingke Bai[SUP] 1 [/SUP], Zhe Xu[SUP] #[/SUP][SUP] 2 [/SUP], Yan Hu[SUP] #[/SUP][SUP] 1 [/SUP], Mengmeng Qu[SUP] 1 [/SUP], Juan Cheng[SUP] 2 [/SUP], Shengdong Luo[SUP] 1 [/SUP], Zengtao Yao[SUP] 1 [/SUP], Hongyan Gao[SUP] 1 [/SUP], Yenv Ma[SUP] 1 [/SUP], Rong Gao[SUP] 1 [/SUP], Jun Hou[SUP] 1 [/SUP], Shaojie Xin[SUP] 3 [/SUP], Panyong Mao[SUP] 4 [/SUP]
Affiliations
- PMID: 33990223
- DOI: 10.1186/s40001-021-00515-9
Abstract
Background: Hematological comparison of coronavirus disease (COVID-19) and other viral pneumonias can provide insights into COVID-19 treatment.
Methods: In this retrospective case-control single-center study, we compared the data of 126 patients with viral pneumonia during different outbreaks [severe acute respiratory syndrome (SARS) in 2003, influenza A (H1N1) in 2009, human adenovirus type 7 in 2018, and COVID-19 in 2020].
Results: One of the COVID-19 characteristics was a continuous decline in the hemoglobin level. The neutrophil count was related to the aggravation of COVID-19 and SARS. Thrombocytopenia occurred in patients with SARS and severe COVID-19 even at the recovery stage. Lymphocytes were related to the entire course of adenovirus infection, recovery of COVID-19, and disease development of SARS.
Conclusions: Dynamic changes in hematological counts could provide a reference for the pathogenesis and prognosis of pneumonia caused by respiratory viruses in clinics.
Keywords: Adenovirus; COVID-19; H1N1; Hematology; SARS-CoV-2.